1,994
Views
34
CrossRef citations to date
0
Altmetric
Research Article

QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes

, , , &
Pages 1047-1056 | Received 29 May 2014, Accepted 15 Jun 2014, Published online: 17 Jul 2014

References

  • Aboelwafa A, El-Setouhy DA, Elmeshad AN. (2010). Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS PharmSciTech 11:1591–602
  • Ahad A, Aqil M, Kohli K, et al. (2011). Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Del 8:213–24
  • Ahad A, Aqil M, Ali A. (2014). Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-Cineole. Int J Biol Macromol 64:144–9
  • Ahad A, Aqil M, Kohli K, et al. (2013). Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm 443:26–38
  • Arora S, Ojha SK, Vohora D. (2009). Characterisation of streptozotocin induced diabetes mellitus in Swiss Albino mice. Glob J Pharm 3:81–4
  • Balakrishnan P, Shanmugam S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
  • Beg S, Swain S, Singh HP, et al. (2012). Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 13:1416–27
  • Chaudhary H, Kohli K, Amin S, et al. (2011). Optimization and formulation design of gels of diclofenac and curcumin for transdermal drug delivery by Box-Behnken statistical design. J Pharm Sci 100:580–93
  • Chaudhary H, Rohilla A, Rathee P, Kumar V. (2013). Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J Biol Macromol 55:246–53
  • Chawla V, Saraf SA. (2012). Rheological studies on solid lipid nanoparticles based carbopol gels of aceclofenac. Colloids Surf B: Biointerfaces 92:293–8
  • Csoka G, Marton S, Zelko R, et al. (2007). Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Sci 65:233–7
  • Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–85
  • Draize JH, Woodward G, Calvery HO. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharm Exp Ther 82:377–9
  • Elbary AA, Kassem MA, Samra MMA, Khalil RM. (2008). Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes. Drug Discov Ther 2:94–107
  • El-Kattan A, Asbill CS, Haidar S. (2000). Transdermal testing: practical aspects and methods. PharmSci Tech Today 3:426–30
  • El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Sci 77:43–55
  • EL-Samaligy MS, Afifi NN, Mahmoud EA. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140–8
  • Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
  • Garcia-Gonzalez N, Kellaway IW, Blanco FH, et al. (1994). Influence of glycerol concentration and carbopol molecular weight on swelling and drug release characteristics of metochlopramide hydrogels. Int J Pharm 104:107–13
  • Higuchi T. (1963). Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9
  • Hwang RC, Kowalski DL. (2005). Design of experiments for formulation development. Pharm Tech 1–5
  • Imam SS, Aqil M, Akhtar M, et al. (2013). Formulation by design based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Delivery, Early Online: 1–12, DOI: 10.3109/10717544.2013.870260
  • Jana S, Manna S, Nayak AK, et al. (2014). Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. ColloidsSurf B: Biointerfaces 114:36–44
  • Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D. (2012). Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm 423:303–11
  • Manconi M, Sinico C, Valenti D, et al. (2006). Niosomes as carriers for tretinoin III A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 311:11–19
  • Mokhtar M, Omaima AS, Mohammed AH, Nagia AM. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
  • Mura S, Pirot F, Manconi M, et al. (2007). Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 15:101–8
  • Muzzalupo R, Tavano L, Cassano R, et al. (2011). A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Sci 79:28–35
  • Naik A, Kalia YN, Guy RH. (2000). Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Tech Today 3:318–26
  • Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
  • Reginato MJ, Lazar MA. (1999). Mechanisms by which Thiazolidinediones enhance insulin action. Trends Endocr Metab 10:9–13
  • Rogerson A, Cummings J, Willmott N, Florence AT. (1988). The distribution of doxorubicin in mice administration in niosomes. J Pharm Pharmacother 40:337–42
  • Shumilov M, Touitou E. (2010). Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm 387:26–33
  • Siewert M, Dressman J, Brown CK, Shah VP. (2003). FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4:1–10
  • Singh B, Kumar R, Ahuja N. (2005). Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 22:27–105
  • Souri E, Jalalizadeh H, Saremi S. (2008). Development and validation of a simple and rapid HPLC method for determination of pioglitazone in human plasma and its application to a pharmacokinetic study. J Chromatogr Sci 46:809–12
  • Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes–novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18
  • Tripathi KD. (2003). Essential of medical pharmacology. New Delhi: Jaypee Brother’s Medical Publishers (P) Ltd., 247–51
  • Ubaidulla U, Reddy MV, Ruckmani K, et al. (2007). Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 8:E1–8
  • Varshosaz J, Pardakhty A, Baharanchi SM. (2005). Sorbitan monopalmitate based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv 12:75–82
  • Vitorino C, Almeida J, Gonçalves LM, et al. (2013). Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Control Release 167:301–14
  • Waugh J, Keating GM, Plosker GL, et al. (2006). Pioglitazone – a review of its use in type 2 diabetes mellitus. Drugs 66:85–109
  • Weber E, Moyers-Gonzalez M, Burghelea TI. (2012). Thermorheological properties of a Carbopol gel under shear. J Non-Newt Fluid Mech 183–4:14–24

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.